Complete Up To Date Information about Styquin.
NADA Number: 104-184 | |
| Proprietary Name |
Styquin |
|---|---|
| Sponsor |
Fort Dodge Animal Health, Division of Wyeth Holdings Corp. |
| Sponsor Address |
P. O. Box 1339 Fort Dodge, IA 50501 USA |
| Ingredients |
Butamisole Hydrochloride |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Subcutaneous |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
| Patent Number |
4130651 |
|
Dosage Amount, Indications & Limitations |
522.234 Butamisole hydrochloride. Specifications: The drug contains 11 milligrams of butamisole per milliliter in a solution consisting of 70 percent propylene glycol, 4 percent benzyl alcohol and distilled water. Conditions of use: Dogs Amount: The drug is administered subcutaneously at the rate of 0.1 milliliter per pound of body weight. In problem cases, re-treatment for whipworms may be necessary in approximately 3 months. For hookworms, a second injection should be given 21 days after the initial treatment. Indications: The drug is administered by subcutaneous injection to dogs for the treatment of infections with whipworms (Trichuris vulpis), and the hookworm (Ancylostoma caninum). Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. |